Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy & Cost-Effectiveness of Lactobacillus Reuteri DSM 17938 Administration to Prevent the Risk of Respiratory or Gastrointestinal Infections in Child Day Care Centers: A Randomized, Double Blind, Placebo Control Trial (RDDCT).

NCT01249911 is registered in ClinicalTrials.gov with National Institute of Pediatrics, Mexico as lead sponsor.

NCT NCT01249911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01249911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy & Cost-Effectiveness of Lactobacillus Reuteri DSM 17938 Administration to Prevent the Risk of Respiratory or Gastrointestinal Infections in Child Day Care Centers: A Randomized, Double Blind, Placebo Control Trial (RDDCT).
Lead sponsor
National Institute of Pediatrics, Mexico
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2011
Completion date
June 30, 2011
Enrollment
269 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy infants